Titre : Protéines AAA

Protéines AAA : Questions médicales fréquentes

Termes MeSH sélectionnés :

Ventricular Function, Left
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines AAA : Questions médicales les plus fréquentes", "headline": "Protéines AAA : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines AAA : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-24", "dateModified": "2025-02-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines AAA" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines de transport", "url": "https://questionsmedicales.fr/mesh/D002352", "about": { "@type": "MedicalCondition", "name": "Protéines de transport", "code": { "@type": "MedicalCode", "code": "D002352", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ATPases associated with diverse cellular activities", "alternateName": "ATPases Associated with Diverse Cellular Activities", "url": "https://questionsmedicales.fr/mesh/D000074183", "about": { "@type": "MedicalCondition", "name": "ATPases associated with diverse cellular activities", "code": { "@type": "MedicalCode", "code": "D000074183", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ATP-dependent proteases", "alternateName": "ATP-Dependent Proteases", "url": "https://questionsmedicales.fr/mesh/D049069", "about": { "@type": "MedicalCondition", "name": "ATP-dependent proteases", "code": { "@type": "MedicalCode", "code": "D049069", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ATP-dependent endopeptidases", "alternateName": "ATP-Dependent Endopeptidases", "url": "https://questionsmedicales.fr/mesh/D057065", "about": { "@type": "MedicalCondition", "name": "ATP-dependent endopeptidases", "code": { "@type": "MedicalCode", "code": "D057065", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032.099" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Protease La", "alternateName": "Protease La", "url": "https://questionsmedicales.fr/mesh/D049070", "about": { "@type": "MedicalCondition", "name": "Protease La", "code": { "@type": "MedicalCode", "code": "D049070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032.099.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Protease La", "alternateName": "Protease La", "url": "https://questionsmedicales.fr/mesh/D049070", "about": { "@type": "MedicalCondition", "name": "Protease La", "code": { "@type": "MedicalCode", "code": "D049070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032.099.750" } } } ] }, { "@type": "MedicalWebPage", "name": "ATP-dependent endopeptidases", "alternateName": "ATP-Dependent Endopeptidases", "url": "https://questionsmedicales.fr/mesh/D057065", "about": { "@type": "MedicalCondition", "name": "ATP-dependent endopeptidases", "code": { "@type": "MedicalCode", "code": "D057065", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032.099" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Protease La", "alternateName": "Protease La", "url": "https://questionsmedicales.fr/mesh/D049070", "about": { "@type": "MedicalCondition", "name": "Protease La", "code": { "@type": "MedicalCode", "code": "D049070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032.099.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Protease La", "alternateName": "Protease La", "url": "https://questionsmedicales.fr/mesh/D049070", "about": { "@type": "MedicalCondition", "name": "Protease La", "code": { "@type": "MedicalCode", "code": "D049070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032.099.750" } } }, { "@type": "MedicalWebPage", "name": "N-Ethylmaleimide-sensitive factors", "alternateName": "N-Ethylmaleimide-Sensitive Proteins", "url": "https://questionsmedicales.fr/mesh/D052066", "about": { "@type": "MedicalCondition", "name": "N-Ethylmaleimide-sensitive factors", "code": { "@type": "MedicalCode", "code": "D052066", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.375" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Protéines AAA", "alternateName": "AAA Proteins", "code": { "@type": "MedicalCode", "code": "D000074582", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Tarun M Kapoor", "url": "https://questionsmedicales.fr/author/Tarun%20M%20Kapoor", "affiliation": { "@type": "Organization", "name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA. kapoor@rockefeller.edu." } }, { "@type": "Person", "name": "Tommaso Cupido", "url": "https://questionsmedicales.fr/author/Tommaso%20Cupido", "affiliation": { "@type": "Organization", "name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA." } }, { "@type": "Person", "name": "Rudolf Pisa", "url": "https://questionsmedicales.fr/author/Rudolf%20Pisa", "affiliation": { "@type": "Organization", "name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA." } }, { "@type": "Person", "name": "James Shorter", "url": "https://questionsmedicales.fr/author/James%20Shorter", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A." } }, { "@type": "Person", "name": "Robert T Sauer", "url": "https://questionsmedicales.fr/author/Robert%20T%20Sauer", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Perioperative changes in left ventricular systolic function following surgical revascularization.", "datePublished": "2022-11-10", "url": "https://questionsmedicales.fr/article/36355812", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0277454" } }, { "@type": "ScholarlyArticle", "name": "A graphical analysis of aspects contributing to the spreading of measurements of left ventricular function.", "datePublished": "2023-02-17", "url": "https://questionsmedicales.fr/article/36800058", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10554-023-02796-z" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of left atrial and left ventricular functions with 3D speckle-tracking echocardiography in patients with coronary artery tortuosity.", "datePublished": "2023-10-10", "url": "https://questionsmedicales.fr/article/37817486", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/echo.15702" } }, { "@type": "ScholarlyArticle", "name": "Do Not Withhold Mitral Surgery from Patients with Poor Left Ventricular Function.", "datePublished": "2022-09-05", "url": "https://questionsmedicales.fr/article/36143897", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/medicina58091220" } }, { "@type": "ScholarlyArticle", "name": "Unsupervised Machine Learning for Assessment of Left Ventricular Diastolic Function and Risk Stratification.", "datePublished": "2022-07-12", "url": "https://questionsmedicales.fr/article/35840082", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.echo.2022.06.013" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines de transport", "item": "https://questionsmedicales.fr/mesh/D002352" }, { "@type": "ListItem", "position": 5, "name": "Protéines AAA", "item": "https://questionsmedicales.fr/mesh/D000074582" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines AAA - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines AAA", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines AAA", "description": "Comment diagnostiquer une dysfonction des protéines AAA ?\nQuels tests sont utilisés pour évaluer les protéines AAA ?\nLes biopsies sont-elles utiles pour les protéines AAA ?\nQuels marqueurs biologiques sont associés aux protéines AAA ?\nLes imageries médicales aident-elles au diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=Ventricular+Function,+Left&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines AAA", "description": "Quels symptômes indiquent une anomalie des protéines AAA ?\nLes troubles cognitifs sont-ils liés aux protéines AAA ?\nY a-t-il des symptômes cutanés associés ?\nLes douleurs musculaires sont-elles fréquentes ?\nLes symptômes varient-ils selon les types de protéines AAA ?", "url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=Ventricular+Function,+Left&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines AAA", "description": "Peut-on prévenir les dysfonctionnements des protéines AAA ?\nLes dépistages réguliers sont-ils utiles ?\nL'éducation génétique est-elle importante ?\nLes habitudes alimentaires influencent-elles la santé des protéines ?\nLe stress a-t-il un impact sur les protéines AAA ?", "url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=Ventricular+Function,+Left&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines AAA", "description": "Quels traitements existent pour les dysfonctionnements des protéines AAA ?\nLa thérapie génique est-elle efficace ?\nDes médicaments spécifiques sont-ils disponibles ?\nLes approches nutritionnelles aident-elles ?\nLa physiothérapie est-elle recommandée ?", "url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=Ventricular+Function,+Left&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines AAA", "description": "Quelles complications peuvent survenir avec les protéines AAA ?\nLes maladies cardiovasculaires sont-elles liées ?\nY a-t-il des risques de cancer associés ?\nLes troubles métaboliques sont-ils possibles ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=Ventricular+Function,+Left&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines AAA", "description": "Quels sont les facteurs de risque pour les dysfonctionnements des protéines AAA ?\nL'hérédité joue-t-elle un rôle ?\nLe mode de vie influence-t-il le risque ?\nLes infections peuvent-elles affecter les protéines AAA ?\nLe vieillissement est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=Ventricular+Function,+Left&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des protéines AAA ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques et des analyses protéomiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les protéines AAA ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction cellulaire et des dosages d'ATPase peuvent être effectués." } }, { "@type": "Question", "name": "Les biopsies sont-elles utiles pour les protéines AAA ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les biopsies peuvent aider à évaluer l'expression des protéines AAA dans les tissus." } }, { "@type": "Question", "name": "Quels marqueurs biologiques sont associés aux protéines AAA ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme Hsp70 peuvent être utilisés pour évaluer l'activité des protéines AAA." } }, { "@type": "Question", "name": "Les imageries médicales aident-elles au diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut montrer des anomalies cellulaires, mais n'est pas spécifique aux protéines AAA." } }, { "@type": "Question", "name": "Quels symptômes indiquent une anomalie des protéines AAA ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes incluent la faiblesse musculaire, la fatigue et des troubles neurologiques." } }, { "@type": "Question", "name": "Les troubles cognitifs sont-ils liés aux protéines AAA ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies peuvent entraîner des troubles cognitifs et de la mémoire." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies liées aux protéines AAA peuvent provoquer des éruptions cutanées." } }, { "@type": "Question", "name": "Les douleurs musculaires sont-elles fréquentes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs musculaires peuvent survenir en raison de dysfonctionnements des protéines." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les types de protéines AAA ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type de protéine AAA impliquée et la pathologie." } }, { "@type": "Question", "name": "Peut-on prévenir les dysfonctionnements des protéines AAA ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Les dépistages réguliers sont-ils utiles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des dépistages peuvent aider à identifier précocement les anomalies génétiques." } }, { "@type": "Question", "name": "L'éducation génétique est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation sur les maladies héréditaires peut aider à la prévention." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles la santé des protéines ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé cellulaire et protéique." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les protéines AAA ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la fonction cellulaire et les protéines." } }, { "@type": "Question", "name": "Quels traitements existent pour les dysfonctionnements des protéines AAA ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies géniques et des médicaments ciblant les voies cellulaires." } }, { "@type": "Question", "name": "La thérapie génique est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique montre des résultats prometteurs dans certaines pathologies liées." } }, { "@type": "Question", "name": "Des médicaments spécifiques sont-ils disponibles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs de l'ATPase sont en cours d'étude pour traiter les dysfonctionnements." } }, { "@type": "Question", "name": "Les approches nutritionnelles aident-elles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une nutrition adéquate peut soutenir la fonction cellulaire, mais n'est pas un traitement direct." } }, { "@type": "Question", "name": "La physiothérapie est-elle recommandée ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut aider à gérer les symptômes musculaires et améliorer la fonction." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les protéines AAA ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des maladies neurodégénératives et des troubles musculaires." } }, { "@type": "Question", "name": "Les maladies cardiovasculaires sont-elles liées ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines dysfonctionnements des protéines AAA peuvent augmenter le risque cardiovasculaire." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer associés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans les protéines AAA peuvent être liées à certains types de cancer." } }, { "@type": "Question", "name": "Les troubles métaboliques sont-ils possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements peuvent entraîner des troubles métaboliques variés." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les dysfonctionnements des protéines AAA ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des prédispositions génétiques, l'âge et des facteurs environnementaux." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines mutations génétiques héréditaires augmentent le risque de dysfonction." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les infections peuvent-elles affecter les protéines AAA ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales peuvent perturber la fonction des protéines AAA." } }, { "@type": "Question", "name": "Le vieillissement est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la fonction des protéines et augmenter les risques." } } ] } ] }

Sources (10000 au total)

Perioperative changes in left ventricular systolic function following surgical revascularization.

Nearly 1/3rd of patients undergoing coronary artery bypass graft surgery (CABG) have left ventricular systolic dysfunction. However, the extent, direction and implications of perioperative changes in ... We studied the changes in LVEF among 549 patients with left ventricular systolic dysfunction (LVEF <50%) who underwent CABG as part of the Surgical Treatment for Ischemic Heart Failure (STICH) tria... Of the 549 patients (mean age 61.4±9.55 years, and 72 [13.1%] women), 145 (26.4%) had a >10% improvement in LVEF, 369 (67.2%) had no change and 35 (6.4%) had >10% worsening of LVEF following CAB... Among patients with ischemic cardiomyopathy undergoing CABG, 26.4% had >10% improvement in LVEF. An improvement in LVEF was more likely in patients with lower preoperative LVEF and was associated w...

Evaluation of left atrial and left ventricular functions with 3D speckle-tracking echocardiography in patients with coronary artery tortuosity.

Tortuosity in the coronary arteries is a very common entity encountered during angiography. The effect of coronary artery tortuosity (CAT) on the myocardium has not been completely investigated. The a... Seventy-five patients with CAT and 80 age- and gender-matched controls who proved to have normal coronary angiograms (CAG) were enrolled into the study. Following CAG, the 2D images were obtained firs... The LAS-r, LAS-active, and LV-GLS were significantly depressed in the CAT (+) group (p < .001, p < .001, p = .012, respectively). The multivariate regression models demonstrated that LAS-r (p < .001),... The current study is the first to focus on the assessing both LA and LV myocardial dynamics in CAT (+) patients by strain echocardiography. The results of our study support the patients with CAT may h...

Unsupervised Machine Learning for Assessment of Left Ventricular Diastolic Function and Risk Stratification.

The 2016 American Society of Echocardiography guidelines have been widely used to assess left ventricular diastolic function. However, limitations are present in the current classification system. The... Baseline demographics, heart failure hospitalization, and all-cause mortality data were obtained for all adult patients who underwent transthoracic echocardiography at Mayo Clinic Rochester in 2015. P... Among 24,414 patients (mean age, 63.6 ± 16.2 years), all-cause mortality occurred in 4,612 patients (18.9%) during a median follow-up period of 3.1 years. The algorithm determined three clusters with ... Unsupervised machine learning identified physiologically and prognostically distinct clusters on the basis of nine diastolic function Doppler variables. The clusters can be potentially applied in echo...

Is increased myocardial triglyceride content associated with early changes in left ventricular function? A

Type 2 diabetes (T2D) and obesity induce left ventricular (LV) dysfunction. The underlying pathophysiological mechanisms remain unclear, but myocardial triglyceride content (MTGC) could be involved.... This study aimed to determine which clinical and biological factors are associated with increased MTGC and to establish whether MTGC is associated with early changes in LV function.... A retrospective study was conducted using five previous prospective cohorts, leading to 338 subjects studied, including 208 well-phenotyped healthy volunteers and 130 subjects living with T2D and/or o... MTGC content increased with age, body mass index (BMI), waist circumference, T2D, obesity, hypertension, and dyslipidemia, but the only independent correlate found in multivariate analysis was BMI (p=... Predicting MTGC remains a challenge in routine clinical practice, as only BMI independently correlates with increased MTGC. MTGC may play a role in LV dysfunction but does not appear to be involved in...

Echocardiographic pattern of left ventricular function recovery in tachycardia-induced cardiomyopathy patients.

Tachycardia-induced cardiomyopathy (TCM) represents a partially reversible type of cardiomyopathy (CM) that is often underdiagnosed and cardiac chamber remodelling in TCM remains incompletely understo... We identified patients with reduced ejection fraction (≤50%) and/or atrial fibrillation or flutter with a left ventricular ejection fraction that improved from baseline (≥15% in left ventricular eject... TCM patients have a specific pattern of functional recovery with persistent remodelling of the left atria and left ventricle. Several echocardiographic parameters might help identify TCM before treatm...

Improvement of hypertension control and left-ventricular function after cure of primary hyperparathyroidism.

Cardiovascular mortality is significantly higher in patients with primary hyperparathyroidism (PHPT) compared to the general population. The role of the renin-angiotensin-aldosterone system (RAAS) as ... In 45 consecutive, hypercalcemic PHPT patients (91% female, 20 normotensive, mean age 54.6 ± 14.6), laboratory examinations, and 24 h ambulatory blood pressure monitoring (ABPM) were performed before,... Both in patients with normotension (NT) and HT, lower calcemia and parathyroid hormone (PTH) as well as higher phosphatemia were observed on follow-up, while B-type natriuretic peptide, aldosterone, p... PTX was shown to significantly reduce BP, LV hypertrophy and diastolic dysfunction parameters in PHPT patients with HT, and improve systolic function in all PHPT patients....

Impact of Rheumatic Process in Left and Right Ventricular Function in Patients with Mitral Regurgitation.

Mitral regurgitation (MR) burdens the left and right ventricles with a volume or pressure overload that leads to a series of compensatory adaptations that eventually lead to ventricular dysfunction, a... Evaluate whether rheumatic etiology is associated with ventricular dysfunction in patients with chronic MR.... The study population comprised patients aged 18 years or older included in the registry who had echocardiography performed at the National Cardiovascular Center Harapan Kita in Indonesia during the st... The current study included 1,130 patients with significant isolated degenerative MR and 276 patients with rheumatic MR. Patients with rheumatic MR were younger and had a higher prevalence of atrial fi... Rheumatic etiology was independently associated with more impaired left ventricular function; however, rheumatic etiology was not associated with reduced right ventricular systolic function in a patie...